
    
      Design: This is an exploratory study in a single center, observer masked, active control,
      randomized trial.

      Overall, 30 subjects with VLU who have persistent wounds and have been previously treated
      with silver based therapy will be 1:1 randomized to receive up to four applications over up
      to four weeks of Study Device or Comparator (silver impregnated contact layer dressing -
      ActicoatÂ®) with 2 weeks follow up period.

      Outcomes: Primary outcome is the change in bacterial load compared to baseline. Secondary
      outcomes: healing rate, complete healing at 6 weeks, pain, quality of life (QOL) measurements
      and adverse events.
    
  